VGXI

VGXI is a leader in the field of plasmid DNA contract manufacturing, with over 20 years of experience providing high-quality products to biomedical researchers worldwide. VGXI supports clients developing DNA vaccines, immunotherapies, cell therapies, and gene therapies. VGXI's portfolio includes high-quality plasmids for preclinical research, high-purity (HD) plasmids as critical raw materials for GMP viral vector production or pharmaceutical/toxicology studies, cGMP plasmid DNA for clinical use through commercial supply, and custom services.